Clinical Trial Update: A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ocular blood flow effects of unoprostone isopropyl in adults with dry age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration

Drugs mentioned

• Unoprostone isopropyl (unoprostone isopropyl)

Snippet

Sponsor: Sucampo Pharma Americas, LLC | Conditions: Dry Age-related Macular Degeneration | Phase 2 | Status: COMPLETED